Free Trial

Genpact (NYSE:G) Price Target Raised to $65.00

Genpact logo with Business Services background

Genpact (NYSE:G - Get Free Report) had its price objective increased by stock analysts at Needham & Company LLC from $55.00 to $65.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a "buy" rating on the business services provider's stock. Needham & Company LLC's target price would suggest a potential upside of 18.54% from the company's previous close.

Several other brokerages have also recently issued reports on G. Robert W. Baird upped their target price on shares of Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and upped their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, TD Cowen raised Genpact from a "hold" rating to a "buy" rating and boosted their target price for the company from $45.00 to $60.00 in a research report on Friday. Six investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $48.44.

Get Our Latest Research Report on G

Genpact Stock Performance

NYSE G traded up $0.40 on Friday, hitting $54.84. 1,196,832 shares of the company traded hands, compared to its average volume of 1,492,132. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The business's 50 day moving average price is $45.09 and its 200-day moving average price is $41.41. The company has a market capitalization of $9.67 billion, a price-to-earnings ratio of 19.32, a P/E/G ratio of 1.63 and a beta of 1.20. Genpact has a 52-week low of $30.23 and a 52-week high of $56.76.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.61% and a net margin of 10.77%. Equities analysts expect that Genpact will post 3.08 earnings per share for the current year.

Insider Buying and Selling

In other news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the transaction, the chief executive officer now directly owns 267,404 shares of the company's stock, valued at $11,926,218.40. This represents a 4.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Piyush Mehta sold 12,000 shares of the business's stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares of the company's stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 35,058 shares of company stock valued at $1,558,675 over the last quarter. 2.80% of the stock is currently owned by company insiders.

Institutional Trading of Genpact

Several large investors have recently bought and sold shares of the business. JPMorgan Chase & Co. lifted its holdings in Genpact by 192.8% in the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock valued at $122,701,000 after acquiring an additional 2,060,595 shares during the last quarter. Tandem Investment Advisors Inc. lifted its position in Genpact by 390.5% in the fourth quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider's stock valued at $91,480,000 after buying an additional 1,695,706 shares during the last quarter. Victory Capital Management Inc. boosted its stake in Genpact by 18.1% during the fourth quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock worth $423,205,000 after buying an additional 1,511,790 shares during the period. Los Angeles Capital Management LLC acquired a new stake in shares of Genpact during the third quarter valued at about $19,779,000. Finally, Geode Capital Management LLC raised its stake in shares of Genpact by 12.6% in the 3rd quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider's stock valued at $148,142,000 after acquiring an additional 413,646 shares during the period. Hedge funds and other institutional investors own 96.03% of the company's stock.

Genpact Company Profile

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Stories

Analyst Recommendations for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines